The Facts.
Media

What’s Going On With Ethereum Classic?

Ethereum Classic (CRYPTO: ETC) has gained roughly 12% to $20.26 since Tuesday evening amid Donald Trump winning the 2024 presidential election. read more ​  ​Ethereum Classic (CRYPTO: ETC) has gained roughly 12% to $20.26 since Tuesday evening amid Donald Trump winning the 2024 presidential election. read more 

Read More
Media

No Middleman, No Markup: How Red Mesa Is Slashing Costs With Around-The-Clock Hemp Refinement

By bypassing brokers and relying on an efficient, around-the-clock refinement process, Red Mesa aims to reduce costs and ensure consistency. read more ​  ​By bypassing brokers and relying on an efficient, around-the-clock refinement process, Red Mesa aims to reduce costs and ensure consistency. read more 

Read More
Media

Ameresco (AMRC) Misses Q3 Earnings Estimates

Ameresco (NYSE: AMRC) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.40 per share a year ago. These figures are adjusted for non-recurring items. read more ​  ​Ameresco (NYSE: AMRC) came out with quarterly earnings of $0.32 per share, missing

Read More
Media

Fortinet Q3 Earnings: Revenue Beat, EPS Beat, Billings Up 6%, Shares Slide

Fortinet reported third-quarter revenue of $1.51 billion, beating the consensus estimate of $1.48 billion. read more ​  ​Fortinet reported third-quarter revenue of $1.51 billion, beating the consensus estimate of $1.48 billion. read more 

Read More
Media

Trump Says He’d Replace Income Taxes With Tariffs: The Potential Economic Fallout

Trump’s policy of high tariffs and lower taxes is unclear. Replacing income tax with tariffs would require extensive legislative action. Experts doubt its feasibility due to potential negative impacts. read more ​  ​Trump’s policy of high tariffs and lower taxes is unclear. Replacing income tax with tariffs would require extensive legislative action. Experts doubt its

Read More
Media

EXCLUSIVE: From Surviving Chavez’s Venezuela To The CBD Crash – CEO Reveals How To Profit In A Market Stuck On Repeat

Jaunty’s CEO Nicolas Guarino knows survival, having led his family through Venezuela’s crisis before facing a 99% CBD market crash in the USA. Ever feel like the CBD market is on autopilot, stuck in a cycle of repetitive products and shrinking profit margins? For cannabis investors, this stuck-on-repeat dynamic has meant intense price pressure and

Read More
Media

Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise

The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates. read more ​  ​The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates. read more 

Read More
Media

Doximity Reports Strong Q2 Earnings Results, Shares Soar

Doximity shares are surging in Thursday’s after-hours session after the company reported better-than-expected financial results for the second quarter. read more ​  ​Doximity shares are surging in Thursday’s after-hours session after the company reported better-than-expected financial results for the second quarter. read more 

Read More
Media

Bitcoin Hits Fresh All-Time High, Ethereum Rallies: ‘Altseason Hasn’t Even Begun,’ Trader Says

Bitcoin briefly hit a fresh all-time high of $76,872 on Thursday before retreating, with financial markets continuing their rally in the wake of Donald Trump winning a second term in office. read more ​  ​Bitcoin briefly hit a fresh all-time high of $76,872 on Thursday before retreating, with financial markets continuing their rally in the

Read More
Media

UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis

A UK-funded study will explore psilocybin’s potential to treat opioid addiction, with a focus on reducing high relapse rates. read more ​  ​A UK-funded study will explore psilocybin’s potential to treat opioid addiction, with a focus on reducing high relapse rates. read more 

Read More
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.